419 related articles for article (PubMed ID: 27795442)
21. Highly efficient vaccines for Bluetongue virus and a related Orbivirus based on reverse genetics.
Roy P
Curr Opin Virol; 2020 Oct; 44():35-41. PubMed ID: 32610251
[TBL] [Abstract][Full Text] [Related]
22. A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus.
Nunes SF; Hamers C; Ratinier M; Shaw A; Brunet S; Hudelet P; Palmarini M
J Virol; 2014 Nov; 88(21):12222-32. PubMed ID: 25142610
[TBL] [Abstract][Full Text] [Related]
23. Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge.
Moreno S; Calvo-Pinilla E; Devignot S; Weber F; Ortego J; Brun A
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008942. PubMed ID: 33275608
[TBL] [Abstract][Full Text] [Related]
24. The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2
Utrilla-Trigo S; Jiménez-Cabello L; Calvo-Pinilla E; Marín-López A; Lorenzo G; Sánchez-Cordón P; Moreno S; Benavides J; Gilbert S; Nogales A; Ortego J
J Virol; 2022 Feb; 96(3):e0161421. PubMed ID: 34787454
[TBL] [Abstract][Full Text] [Related]
25. Recombinant bluetongue virus with hemagglutinin epitopes in VP2 has potential as a labeled vaccine.
Guo Y; Huang L; Bi K; Xu Q; Bu Z; Wang F; Sun E
Vet Microbiol; 2020 Sep; 248():108825. PubMed ID: 32891953
[TBL] [Abstract][Full Text] [Related]
26. Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen.
Stewart M; Dubois E; Sailleau C; Bréard E; Viarouge C; Desprat A; Thiéry R; Zientara S; Roy P
Vaccine; 2013 Jan; 31(3):553-8. PubMed ID: 23159460
[TBL] [Abstract][Full Text] [Related]
27. The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA.
van Rijn PA; Maris-Veldhuis MA; van Gennip RGP
Viruses; 2021 May; 13(5):. PubMed ID: 34067226
[TBL] [Abstract][Full Text] [Related]
28. Genetically engineered multi-component virus-like particles as veterinary vaccines.
Pearson LD; Roy P
Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():381-9. PubMed ID: 8270267
[TBL] [Abstract][Full Text] [Related]
29. Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheep.
Pérez de Diego AC; Athmaram TN; Stewart M; Rodríguez-Sánchez B; Sánchez-Vizcaíno JM; Noad R; Roy P
PLoS One; 2011; 6(10):e26666. PubMed ID: 22046324
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.
Anderson J; Hägglund S; Bréard E; Comtet L; Lövgren Bengtsson K; Pringle J; Zientara S; Valarcher JF
Clin Vaccine Immunol; 2013 Aug; 20(8):1115-22. PubMed ID: 23720365
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
[TBL] [Abstract][Full Text] [Related]
32. Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.
Martín V; Pascual E; Avia M; Peña L; Valcárcel F; Sevilla N
PLoS One; 2015; 10(11):e0143273. PubMed ID: 26619062
[TBL] [Abstract][Full Text] [Related]
33. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
[TBL] [Abstract][Full Text] [Related]
34. Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.
Martinelle L; Dal Pozzo F; Thys C; De Leeuw I; Van Campe W; De Clercq K; Thiry E; Saegerman C
Vet Res; 2018 Jul; 49(1):63. PubMed ID: 30012223
[TBL] [Abstract][Full Text] [Related]
35. Vaccines for Prevention of Bluetongue and Epizootic Hemorrhagic Disease in Livestock: A North American Perspective.
McVey DS; MacLachlan NJ
Vector Borne Zoonotic Dis; 2015 Jun; 15(6):385-96. PubMed ID: 26086559
[TBL] [Abstract][Full Text] [Related]
36. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
[TBL] [Abstract][Full Text] [Related]
37. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
[TBL] [Abstract][Full Text] [Related]
38. Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen.
Franceschi V; Capocefalo A; Calvo-Pinilla E; Redaelli M; Mucignat-Caretta C; Mertens P; Ortego J; Donofrio G
Vaccine; 2011 Apr; 29(16):3074-82. PubMed ID: 21320537
[TBL] [Abstract][Full Text] [Related]
39. Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.
Feenstra F; van Rijn PA
Crit Rev Microbiol; 2017 Mar; 43(2):142-155. PubMed ID: 27800699
[TBL] [Abstract][Full Text] [Related]
40. Implications of a conserved region of bluetongue virus protein VP2 in cross-neutralisation of bluetongue virus serotypes.
Jyothi SJ; Patil SR; Reddy NY; Panduranga RP; Madala U; Prakash GM; Putty K
Onderstepoort J Vet Res; 2020 Oct; 87(1):e1-e6. PubMed ID: 33054261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
